Add BrightSurf on Google Email

The Lancet


Addition of chemotherapy to radiotherapy continues to increase survival in patients with brain tumors for up to 5 years

The EORTC-NCIC trial found that adding chemotherapy to radiotherapy significantly increases survival in glioblastoma patients, with improved outcomes seen across all clinical prognostic subgroups. The study suggests testing tumour MGMT gene methylation status to identify patients most likely to benefit from this treatment.

SourceThe Lancet_DELETED·JournalThe Lancet Oncology·DateMar 8, 2009

Chronic diseases are leading causes of death in OPT

In the occupied Palestinian territory (OPT), chronic diseases such as heart disease, cerebrovascular disease, diabetes, and cancer are leading causes of death. The Palestinian National Authority's response has been limited due to military occupation and its consequences on the healthcare system.

SourceThe Lancet_DELETED·JournalThe Lancet·DateMar 4, 2009

Palestinians lack basic human security

Threats to Palestinian life and well-being have intensified since 2000, including killings, injuries, and destruction of homes and properties. Access to basic services like fuel, electricity, water, and sanitation is disrupted by Israeli restrictions and military incursions.

SourceThe Lancet_DELETED·JournalThe Lancet·DateMar 4, 2009

Drug doubles survival of patients with pre-leukemia

A new study published in The Lancet Oncology found that azacitidine significantly improves the survival of patients with high-risk forms of myelodysplastic syndromes (MDS). Patients treated with azacitidine had a median overall survival of 24.5 months, compared to 15 months for those receiving conventional care.

SourceThe Lancet_DELETED·JournalThe Lancet Oncology·DateFeb 17, 2009

Imaging for low-back pain without serious underlying conditions does not improve clinical outcomes

A meta-analysis of randomized controlled trials found no significant differences between immediate imaging and usual clinical care for patients with acute or sub-acute low-back pain. The authors recommend refraining from routine imaging unless serious underlying conditions are suspected, to reduce unnecessary tests and improve patient ...

SourceThe Lancet_DELETED·JournalThe Lancet·DateFeb 5, 2009